SC 13D Filing

Company

Traws Pharma, Inc.

Filed

April 8, 2024

Accession Number

0000929638-24-001418

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →